Nasdaq grts.

Find the latest Financials data for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com.WebEMERYVILLE, Calif., June 13, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...May 3, 2021 · Gritstone bio (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. May 31, 2022 · EMERYVILLE, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ... Here's Why We're Not Too Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Situation May 26. Consensus revenue estimates increase to US$46.1m May 13. First quarter 2021 earnings released: EPS US$0.10 (vs US$0.71 loss in 1Q 2020) May 07. Gritstone Oncology EPS beats by $0.41, beats on revenue

Apr 19, 2021 · The big shareholder groups in Gritstone Oncology, Inc. (NASDAQ:GRTS) have power over the company. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have ...

Gritstone bio ( NASDAQ: GRTS) is developing a second-generation covid vaccine that is designed to work in two ways; first, it will generate a robust neutralizing antibodies response, and second ...

EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world's most potent vaccines, today announced... -- 10,000 participant randomized Phase 2b study will evaluate Gritstone s self-amplifying mRNA (samRNA) vaccine candidate containing Spike plus ...Gritstone Bio ($NASDAQ:GRTS) is a clinical-stage immuno-oncology company focused on developing neoantigen cancer vaccines to treat patients with solid tumors.GRTS; Advanced Chart. Stock Screener · Earnings Calendar · Sectors · Nasdaq. Search Ticker. |. GRTS U.S.: Nasdaq. Gritstone bio Inc. Watchlist. Alert. NEW. Set ...EMERYVILLE, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.

May 6, 2021 · Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.

Find the latest Institutional Holdings data for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com.

Find the latest Earnings Report Date for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com.(Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, today announced that Andrew ...Nov 30, 2023 · The average price predicted for Gritstone Bio Inc (GRTS) by analysts is $10.40, which is $9.08 above the current market price. The public float for GRTS is 87.55M, and at present, short sellers hold a 9.62% of that float. On November 30, 2023, the average trading volume of GRTS was 2.33M shares. The electric vehicle boom is accelerating – and ... 16 ต.ค. 2566 ... The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. ... GRTS + ...About Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.EMERYVILLE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...

Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.Find the latest Insider Activity data for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com.Jan 9, 2022 · Insiders seem to have made the most of their holdings by selling US$221k worth of Gritstone bio, Inc. (NASDAQ:GRTS) stock at an average sell price of US$22.10 during the past year. The company's ... 9 มี.ค. 2566 ... (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world's most potent vaccines, today reported financial results ...Gritstone bio (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.EMERYVILLE, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...Jun 3, 2021 · The Last 12 Months Of Insider Transactions At Gritstone bio. The Executive VP & CTO, Roman Yelensky, made the biggest insider sale in the last 12 months. That single transaction was for US$221k ...

EMERYVILLE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...

GRTS Historical Data. Get up to 10 years of daily historical stock prices & volumes. The "Close/Last" is the “adjust consolidated close price”. Data provided by Edgar Online . The net and ...EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...Sep 28, 2023 · Gritstone bio, Inc. (NASDAQ:GRTS) shares rose 37% to $1.63 in pre-market trading after the company announced it was awarded a BARDA contract to conduct a Phase 2b comparative study evaluating a ... You can practice and explore trading GRTS stock methods without spending real money on the virtual paper trading platform. Webull offers GRTS Ent Holdg (GRTS) historical stock prices, in-depth market analysis, NASDAQ: GRTS real-time stock quote data, in-depth charts, free GRTS options chain data, and a fully built financial calendar to help you ... Find out why GRTS stock is a Hold. ... (NASDAQ:GRTS) in the spotlight. The company is advancing its pipeline on several fronts, has a collaboration deal with a well-known drug maker, and its lead ...The average one-year price target for Gritstone Bio (NASDAQ:GRTS) has been revised to 10.71 / share. This is an increase of 22.09% from the prior estimate of 8.77 dated August 31, 2023.Gritstone bio, Inc. (GRTS) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 1.3100 -0.0100 (-0.76%) As of 03:13PM EST. Market open. 1d 5d 1m 6m YTD 1y 5yGet free real-time information on GRT/USD quotes including GRT/USD live chart. Indices Commodities Currencies Stocks

GRTS Latest After Hours Trades. Select time range to see more trades: Last 100 Trades. After Hours Time (ET) After Hours Price. After Hours Share Volume. 18:30:18. $2.47. 9.

EMERYVILLE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...

The following insider purchased GRTS shares in the last 24 months: Vassiliki Economides ($22,800.00). How much insider buying is happening at Gritstone bio? Insiders have purchased a total of 12,000 GRTS shares in the last 24 months for a total of $22,800.00 bought.The average price predicted for Gritstone Bio Inc (GRTS) by analysts is $10.40, which is $9.08 above the current market price. The public float for GRTS is 87.55M, and at present, short sellers hold a 9.62% of that float. On November 30, 2023, the average trading volume of GRTS was 2.33M shares. The electric vehicle boom is accelerating – and ...You can practice and explore trading GRTS stock methods without spending real money on the virtual paper trading platform. Webull offers GRTS Ent Holdg (GRTS) historical stock prices, in-depth market analysis, NASDAQ: GRTS real-time stock quote data, in-depth charts, free GRTS options chain data, and a fully built financial calendar to help you ... EMERYVILLE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...Second Quarter 2023 Financial Results. Cash, cash equivalents, marketable securities and restricted cash were $122.3 million as of June 30, 2023, compared to $185.2 million as of December 31, 2022 ...EMERYVILLE, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...So spare a thought for the long term shareholders of Gritstone bio, Inc. (NASDAQ:GRTS); the share price is down a whopping 70% in the last three years. That might cause some serious doubts about ...Nov 21, 2023 · Eric Enderson. November 21, 2023. In the last trading session, 1.28 million Gritstone Bio Inc (NASDAQ:GRTS) shares changed hands as the company’s beta touched 0.47. With the company’s per share price at $1.32 changed hands at -$0.04 or -2.94% during last session, the market valuation stood at $125.85M. GRTS’s last price was a discount ... The latest price target for . Gritstone Bio (NASDAQ: GRTS) was reported by Piper Sandler on Thursday, September 28, 2023.The analyst firm set a price target for 7.00 expecting GRTS to rise to ...

EMERYVILLE, Calif., April 04, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...While there are scores of intriguing bargains in biotech right now, Gritstone bio (GRTS 3.79%) and Sorrento Therapeutics (SRNE.Q 8.33%) both have the potential to deliver life-changing gains for ...Nov 8, 2023 · On November 8, 2023, Gritstone Bio Inc ( NASDAQ:GRTS ), a clinical-stage biotechnology company, announced its financial results for the third quarter ended September 30, 2023, along with updates ... Instagram:https://instagram. call option price calculatorbest cryptocurrency courseameran stocksmh stock forecast Gritstone Bio Inc (NASDAQ:GRTS) trade information. After registering a 2.73% upside in the last session, Gritstone Bio Inc (GRTS) has traded red over the past five days. The stock hit a weekly high of 2.0200 this Friday, 11/03/23, jumping 2.73% in its intraday price action. The 5-day price performance for the stock is -0.53%, and -21.99% over ...Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. tops shipssnkr stock Mar 8, 2022 · Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. vanguard sandp 500 index fund admiral Find out why GRTS stock is a Hold. ... (NASDAQ:GRTS) in the spotlight. The company is advancing its pipeline on several fronts, has a collaboration deal with a well-known drug maker, and its lead ...The average price predicted for Gritstone Bio Inc (GRTS) by analysts is $10.40, which is $9.08 above the current market price. The public float for GRTS is 87.55M, and at present, short sellers hold a 9.62% of that float. On November 30, 2023, the average trading volume of GRTS was 2.33M shares. The electric vehicle boom is accelerating – and ...Celebrations may be in order for Gritstone bio, Inc. (NASDAQ:GRTS) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company. The analysts have ...